Skip to main content

Syngenta, Chromatin Extend Gene Stacking Technology Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Chromatin today announced an extension of its agreement with Syngenta Biotechology for use of Chromatin's gene stacking technology for soybean applications.

The deal builds on earlier agreements between the two firms. The original deal, forged in 2007, gave Syngenta non-exclusive rights to use Chromatin's technology for trait genes in corn and soybean. Two years later, Syngenta acquired exclusive worldwide research and commercial license rights to the technology for use in sugar cane.

The two firms today said that they have begun work to further the gene stacking technology for use on soybeans. They did not elaborate.

Terms of the extension were not disclosed.

Chromatin is based in Chicago and develops technologies for use in the agricultural, energy, chemical, nutritional, and pharmaceutical areas. Its gene stacking technology uses a plant's own DNA to deliver genes on a mini-chromosome, genetic elements built to deliver multiple traits "and accelerate the development of new products, providing new benefits to growers, industrial bioprocessors, and consumers," Chromatin said in a statement.

Syngenta is an agribusiness based in Basel, Switzerland, engaged in the development, manufacture, and marketing of products for the enhancement of crop yields and food quality.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.